Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 9340 | Other Identifier | CPMC IRB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients presenting for lung volume reduction are very high risk patients and it is important they receive the best anesthetic available. This study aims to answer which is the best anesthetic for managing such cases.
The anesthetic technique for lung volume reduction surgery consists of a thoracic epidural in combination with a general anesthetic. The thoracic epidural is routine for this operation and allows administration of local anesthetics and painkillers in the epidural space which results in profound pain relief in the area of surgery. The epidural is routinely used for pain control during the surgery and after the surgery when the patient is awake.
The general anesthetic used may be a volatile agent (gas for example Desflurane), which is administered through the anesthesia machine, or an intravenous anesthetic agent, which is administered into a vein through an intravenous line as a continuous infusion (example Propofol). The use of an anesthetic agent and an epidural often causes a decrease in blood pressure which is treated with medication. The investigators are comparing the two anesthetic techniques regarding their effect on blood pressure and the amount of medication needed to treat it.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Propofol | Active Comparator | Patients will receive Propofol as an intravenous (IV) agent, which is administered into a vein through an IV line as a continuous infusion. |
|
| Desflurane | Active Comparator | Patients will receive Desflurane as a gas that is administered through an anesthesia machine. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Propofol | Drug | Intravenous administration |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Time of discontinuation of anesthetic to eye opening | Measured in minutes | Up to 30 minutes (during procedure) |
| Time of discontinuation of anesthetic to tidal volume (TV) 300ml | Measured in minutes | Up to 30 minutes (during procedure) |
| Time of discontinuation of anesthetic to extubation | Measured in minutes | Up to 30 minutes (during procedure) |
| Measure | Description | Time Frame |
|---|---|---|
| Duration of intensive care unit (ICU) stay | Measured in days | Up to 1 month from procedure |
| Duration of hospital stay | Measured in days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bessie Kachulis, MD | Columbia University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Columbia University Irving Medical Center | New York | New York | 10032 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015742 | Propofol |
| D000077335 | Desflurane |
| ID | Term |
|---|---|
| D010636 | Phenols |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
Not provided
Not provided
Patients were randomized to receive propofol or desflurane as the maintenance anesthetic.
Not provided
Not provided
Not provided
Not provided
| Desflurane | Drug | Volatile administration |
|
|
| Up to 1 month from procedure |
| D006838 |
| Hydrocarbons |
| D009930 | Organic Chemicals |
| D005019 | Ethyl Ethers |
| D004987 | Ethers |
| D008738 | Methyl Ethers |
| D006845 | Hydrocarbons, Fluorinated |
| D006846 | Hydrocarbons, Halogenated |